We are live on
!
Find out more
RC
Roundview Capital Portfolio holdings
AUM
$1.61B
1-Year Est. Return
16.92%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+16.92%
3 Year Est. Return
+63.17%
5 Year Est. Return
+78.22%
10 Year Est. Return
+279.65%
AUM
$387M
AUM Growth
+$37.6M
(+11%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
4.41%
Top 10 Holdings %
Top 10 Hldgs %
25.66%
Holding
238
New
25
Increased
107
Reduced
61
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
USG
Usg
USG
|
+$1.46M |
| 2 |
Fastenal
FAST
|
+$1.28M |
| 3 |
Amazon
AMZN
|
+$1.09M |
| 4 |
Equifax
EFX
|
+$930K |
| 5 |
Charter Communications
CHTR
|
+$900K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.34M |
| 2 |
SLB Ltd
SLB
|
+$806K |
| 3 |
Cencora
COR
|
+$725K |
| 4 |
Gilead Sciences
GILD
|
+$724K |
| 5 |
NewMarket
NEU
|
+$681K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.37% |
| 2 | Industrials | 9.38% |
| 3 | Technology | 9.36% |
| 4 | Healthcare | 7.64% |
| 5 | Communication Services | 7.53% |
Similar funds
FWP
GCP
ACB
SCM
SCI
PPW
BW
Roundview Capital's Q4 2017 Portfolio in Review
As of Q4 2017, Roundview Capital held 238 positions worth $387M, up 11% from $350M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Roundview Capital deployed $17.1M of net new capital in Q4 2017, opening 25 new positions and adding to 107 existing holdings. Its largest new stake was Equifax: 8,275 shares worth $976K.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Vanguard Total Bond Market, an estimated $1.34M trimmed.
- Roundview Capital's largest Q4 2017 buy was Equifax: 8,275 shares worth $976K.
- Roundview Capital added most to Usg in Q4 2017, an estimated $1.46M increase.
- Roundview Capital's biggest Q4 2017 reduction was Vanguard Total Bond Market, cutting an estimated $1.34M.
- Roundview Capital fully exited Gilead Sciences in Q4 2017, selling an estimated $724K.
- Roundview Capital's ten largest holdings make up 26% of its $387M portfolio in Q4 2017.
- Roundview Capital opened 25 new positions and closed 11 in Q4 2017.
- Roundview Capital's portfolio value rose 11% quarter-over-quarter to $387M.
Based on Roundview Capital's 13F filing for Q4 2017, filed 7 Feb 2018.